IMLOAD: Immediate Loading of Implants in the Partially or Completely Edentulous Jaw

Sponsor
AZ Sint-Jan AV (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02661412
Collaborator
(none)
150
1
192
0.8

Study Details

Study Description

Brief Summary

The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Since its introduction in the late 1990s, immediate implant loading concepts (IL) have become a frequent alternative for delayed implant procedures. IL concepts reduce chair time, the number of surgical interventions and pain, and offer instant comfort to the patient. Its reduced treatment time results in obvious socioeconomic advantages. Although there is at present abundant evidence that supports IL, evaluation of long-term biological and mechanical stability outcomes of large patient populations could allow quality improvement and more accurate patient selection. The Departments of Oral and Maxillofacial Surgery and the Department of Dentistry of the General Hospital Saint-John Bruges act as one of the pioneers of IL in Belgium, routinely performing the concept since 2001.

    The investigators aim to evaluate the biological and mechanical short- and long-term outcome of IL in partially or completely edentulous patients. Moreover, the investigators aim to detect potential influencing risk factors predicting undesirable prosthetic outcome.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    150 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    Immediate Loading of Implants in the Partially or Completely Edentulous Jaw
    Actual Study Start Date :
    Dec 1, 2015
    Anticipated Primary Completion Date :
    Dec 1, 2030
    Anticipated Study Completion Date :
    Dec 1, 2031

    Outcome Measures

    Primary Outcome Measures

    1. implant survival rate [within 6 months post placement of implants]

      Percentage of people in the study for which implant is still present of the fixture in the oral cavity

    2. implant survival rate [until a maximum of 15 years of follow-up]

      Percentage of people in the study for which implant is still present of the fixture in the oral cavity

    Secondary Outcome Measures

    1. Infection rate [within 6 months post placement of implants]

      Percentage of people in the study that develop an infection at the site of the implant in the oral cavity

    2. Infection rate [until a maximum of 15 years of follow-up]

      Percentage of people in the study that develop an infection at the site of the implant in the oral cavity

    3. correlation between patient-mediated factors and occurrence of implant instability [within 6 months post placement of implants]

      correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon

    4. correlation between patient-mediated factors and occurrence of implant instability [until a maximum of 15 years of follow-up]

      correlation between patient-mediated factors (age, gender, comorbidities, etc) and occurrence of implant instability, as clinically evaluated by the treating surgeon

    5. correlation between clinical factors and the occurrence of implant instability [within 6 months post placement of implants]

      correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon

    6. correlation between clinical factors and the occurrence of implant instability [until a maximum of 15 years of follow-up]

      correlation between clinical factors (surgeon, surgical procedure, etc) as and the occurrence of implant instability, as clinically evaluated by the treating surgeon

    7. correlation between implant characteristics and occurrence of implant instability [within 6 months post placement of implants]

      correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon

    8. correlation between implant characteristics and occurrence of implant instability [until a maximum of 15 years of follow-up]

      correlation between implant characteristics (design/finish/material) and occurrence of implant instability, as clinically evaluated by the treating surgeon

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients of all ages

    • patients of all genders

    • patients with partially or complete edentulous jaw

    • patients treated at the department between 01/01/2001 and 31/12/2015

    Exclusion Criteria:
    • patients not eligible according to abovementioned criteria

    • patients who required horizontal bone augmentation procedures of the complete alveolar bone

    • patients who required a jaw reconstruction after tumor resection, osteoradionecrosis or medication-related osteonecrosis of the jaw

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 General Hospital Saint-John Bruges Bruges Belgium

    Sponsors and Collaborators

    • AZ Sint-Jan AV

    Investigators

    • Principal Investigator: Johan Abeloos, MD, division of maxillofacial surgery, department of surgery, general hospital Saint-John Bruges

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Johan Abeloos, Maxillofacial Surgeon, Head of Department, AZ Sint-Jan AV
    ClinicalTrials.gov Identifier:
    NCT02661412
    Other Study ID Numbers:
    • B049201627038
    First Posted:
    Jan 22, 2016
    Last Update Posted:
    Feb 28, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Johan Abeloos, Maxillofacial Surgeon, Head of Department, AZ Sint-Jan AV
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 28, 2022